This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Buren, A. Articles by Ygge, J. Search for Related Content PubMed PubMed Citation Articles by Buren, A. Articles by Ygge, J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ACETYLSALICYLIC ACID Medline Plus Health Information Transient Ischemic Attack

Stroke, Vol 12, 578-580, Copyright © 1981 by American Heart Association

ARTICLES

Treatment program and comparison between anticoagulants and platelet aggregation inhibitors after transient ischemic attack

A Buren and J Ygge

Transient cerebral ischemic attacks (TIA) are an important warning symptom of threatening stroke from cerebral infarction (CI). A local treatment program aimed at identifying as many individuals with TIA as possible and treating them in a uniform manner is desirable. Platelet aggregation inhibitors with a combination of acetylsalicylic acid and dipyridamole (ASA + DP) has been compared with anticoagulants (AC). The average length of treatment was 24 months and all patients received the treatment for at least 6 months. Sixty patients received AC and 65 ASA + DP. Four patients in the ASA + DP group (6 percent) and 2 in the AC group (3.3 percent) sustained cerebral infarction. These figures are essentially lower than the expected incidence of 15--20 percent.

This article has been cited by other articles:

				M. E Schachter, H. A Tran, and S. S Anand Oral anticoagulants and non-cardioembolic stroke prevention Vascular Medicine, February 1, 2008; 13(1): 55 - 62. [Abstract] [PDF]

				E. Flossmann and P. M. Rothwell Prognosis of vertebrobasilar transient ischaemic attack and minor stroke Brain, September 1, 2003; 126(9): 1940 - 1954. [Abstract] [Full Text] [PDF]

				R. G. Hart, B. S. Boop, and D. C. Anderson Oral Anticoagulants and Intracranial Hemorrhage : Facts and Hypotheses Stroke, August 1, 1995; 26(8): 1471 - 1477. [Abstract] [Full Text]

				Antiplatelet Trialists Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ, January 8, 1994; 308(6921): 81 - 106. [Abstract] [Full Text]

				E. Ott, E. Korner, and H. Lechner Hemorheologic Treatment of Cerebral Reversible Ischemic Episodes with Pentoxifylline A Prospective Study Angiology, June 1, 1988; 39(6): 520 - 525. [Abstract] [PDF]